Hormone signaling via androgen receptor affects breast cancer and prostate cancer in a male patient: A case report
Abstract Background Male breast cancer (MBC) is rare, accounting for only around 1% of all breast cancers. Most MBCs are hormone-driven. Not only the estrogen receptor (ER), but also other steroid hormone receptors, including the androgen receptor (AR) and progesterone receptor (PgR) are expressed i...
Main Authors: | Haruko Takuwa, Wakako Tsuji, Masayuki Shintaku, Fumiaki Yotsumoto |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-12-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12885-018-5216-6 |
Similar Items
-
Estrogen-Related Receptors in Breast Cancer and Prostate Cancer
by: Satoshi eInoue, et al.
Published: (2015-05-01) -
Androgen receptor and prostate cancer
by: Karen E. Livermore, et al.
Published: (2016-06-01) -
Androgen Receptor Splice Variants Contribute to the Upregulation of DNA Repair in Prostate Cancer
by: Yuri Tolkach, et al.
Published: (2022-09-01) -
Transcriptional Profile Associated with Clinical Outcomes in Metastatic Hormone-Sensitive Prostate Cancer Treated with Androgen Deprivation and Docetaxel
by: Natalia Jiménez, et al.
Published: (2022-09-01) -
Characterization of Hormone-Dependent Pathways in Six Human Prostate-Cancer Cell Lines: A Gene-Expression Study
by: Andras Franko, et al.
Published: (2020-10-01)